THE ROLE OF TRANSRECTAL ULTRASOUND METHODS IN THE EARLY DIAGNOSIS OF PROSTATE CANCER

Abstract

The purpose of the study: to study the diagnostic capabilities of transrectal USAng (TRUS) in combination with compression elastography and USAng angiography in the early diagnosis of prostate cancer.
Materials and methods: 120 men examined in the period from 2020 to 2021, who were treated at the oncourology department of the Republican Scientific and Practical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan. The data obtained in the study, along with the results of the studies, were displayed in a specially developed by us patient card, which included passport data, the results of clinical, laboratory and radiological studies.
Results: The contribution of the "TRUS+USAng+EG" complex to the diagnosis of prostate cancer is very significant, especially given the wide prevalence and economic availability, the possibility of assessing not only the prostate, but also the tissues of adjacent organs and formations beyond it.
Conclusions: The usage of the complex "TRUS+USAng+EG" has a specificity of PCa diagnosis of 78.25% (p<0.001), accuracy - 78.83% (p<0.001). Elastography plays a huge role in differentiating prostate cancer from inflammatory diseases of the prostate, so in 88% of cases, prostate cancer is characterized by types III and IV elastograms (p>0.05). Ultrasonic elastography and angiography for suspected prostate cancer are necessary as part of the diagnostic complex.